Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Harvey was diagnosed in May of 2021 when he discovered a tumor on my right femur. Shortly after surgery to remove the tumor he started treatment of 2 rounds of VDT- Pace, then on to 2 stem cell transplants. His FIsH test revealed he had 4/14 and chromosome 1q deletion 1p. On 2/17/22 he was considered in remission.  He was on maintenance through 2022 but his levels climbed in 23 so he switched to Darzalex Faspro. During his second round of treatment he developed a tumor on his jaw. He received his third stem cell transplant, but the tumor continued to grow. He started teclistamab in the fall of 2023. After a few weeks his jaw tumor was gone and his levels were considered at complete response. He has been amazed at his progress. While some of the treatment have been short lived the bi-specifics have shown great promise. He has been married to his wife Carol for 36 years, has two grown children and three grandchildren. He worked as a banker for 38 years, and retired as the Chief Operating Officer of TriStar Bank in December (though he continues to serve on the bank's board). His family enjoys spending time at their lake house where Harvey's hobbies are mostly related to lake life.